Evidence map›Paper›PMID 42178471›Full record

ReviewReviews in endocrine & metabolic disorders2026

Body composition in male hypogonadism: practical considerations to the use of dual-energy x-ray absorptiometry.

Andrea Delbarba, Myriam Amer, Walter Vena, Biagio Cangiano, Emanuele Ferrante, Alessandro Pizzocaro, Alessandro Chilà, Marilina Romeo, Valeria Lanzi, Caterina Buoso and 6 more

Abstract readReview
In one paragraph

Review in Reviews in endocrine & metabolic disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Andrea DelbarbaDepartment of Clinical and Experimental Sciences, SSD Endocrinologia, University of Brescia, ASST Spedali Civili, Brescia, Italy.ORCID http://orcid.org/0000-0002-7474-3451
Myriam AmerEndocrinology, Diabetology and Medical Andrology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.ORCID http://orcid.org/0009-0009-6112-8239
Walter VenaDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.ORCID http://orcid.org/0000-0002-9288-6261
Biagio CangianoDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.ORCID http://orcid.org/0000-0002-2658-744X
Emanuele FerranteEndocrinology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.ORCID http://orcid.org/0000-0002-0556-7650
Alessandro PizzocaroEndocrinology, Diabetology and Medical Andrology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.ORCID http://orcid.org/0000-0003-1664-6183
Alessandro ChilàDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.ORCID http://orcid.org/0009-0008-7209-8533
Marilina RomeoUnit of Endocrinology & Diabetes, Humanitas Gavazzeni Institute, Bergamo, Italy.ORCID http://orcid.org/0000-0002-4569-6561
Valeria LanziEndocrinology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.ORCID http://orcid.org/0009-0007-6078-2410
Caterina BuosoDepartment of Clinical and Experimental Sciences, SSD Endocrinologia, University of Brescia, ASST Spedali Civili, Brescia, Italy.ORCID http://orcid.org/0000-0001-9271-6388
Giorgio TieccoDepartment of Clinical and Experimental Sciences, Unit of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili di Brescia, Brescia, Italy.ORCID http://orcid.org/0000-0002-7366-871X
Matteo RivaDepartment of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.ORCID http://orcid.org/0009-0000-3444-2489
Alfredo BerrutiMedical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia at ASST Spedali Civili, Brescia, Italy.ORCID http://orcid.org/0000-0002-3956-0043
Gherardo MazziottiDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.ORCID http://orcid.org/0000-0001-5458-701X
Alberto FerlinDepartment of Medicine, University of Padova, Padua, Italy.ORCID http://orcid.org/0000-0001-5817-8141
Marco BonomiDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy. m.bonomi@auxologico.it.ORCID http://orcid.org/0000-0001-5454-6074

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Male hypogonadism is associated with significant alterations in body composition, including reduced lean body mass (LBM), increased fat body mass (FBM), particularly visceral adiposity, and impaired muscle function, contributing to frailty and cardiometabolic risk. These changes reflect the disruption of a complex endocrine crosstalk among bone, muscle, and adipose tissue, mediated by cytokines such as osteokines, myokines, and adipokines. This dysregulation promotes the development of osteosarcopenic obesity, a condition characterized by the coexistence of low bone mass, sarcopenia, and excess adiposity. Testosterone (T) plays a central role in maintaining body composition by stimulating muscle protein synthesis, inhibiting adipogenesis, and preserving bone health. Its deficiency, irrespective of etiology, leads to rapid impairment of anabolic pathways, resulting in decreased lean mass and increased fat accumulation. Evidence from clinical and experimental models demonstrates that these alterations are partially reversible with T replacement therapy (TRT), although variability exists depending on the underlying cause of hypogonadism. Dual-energy X-ray absorptiometry (DXA) represents the gold standard for assessing bone mineral density (BMD) and a key tool for evaluating body composition through a three-compartment model. It allows precise quantification of fat and lean mass, as well as their regional distribution, with minimal radiation exposure. In this review, we provide a comprehensive and clinically oriented overview of body composition alterations in male hypogonadism, focusing on underlying pathophysiological mechanisms and the practical application of DXA across different clinical scenarios. We discuss evidence from conditions such as Klinefelter syndrome, Kallmann syndrome, androgen deprivation therapy, HIV infection, and transgender care, aiming to offer a pragmatic framework for integrating body composition assessment into routine practice and improving patient management.

Indexed as

Absorptiometry, PhotonBody CompositionHypogonadismBone DensityHumansMaleTestosteroneTestosteroneAndrogen Deprivation TherapyBody compositionKlinefelter’s syndromeMale hypogonadism. Kallmann’s syndromePLWHTransgender AMAB

Identifiers

PMID42178471
PMCPMC13388776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.